rs142116575

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001166108.2(PALLD):​c.2393T>C​(p.Met798Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00192 in 1,614,134 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M798V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 5 hom. )

Consequence

PALLD
NM_001166108.2 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 1.49

Publications

6 publications found
Variant links:
Genes affected
PALLD (HGNC:17068): (palladin, cytoskeletal associated protein) This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
CBR4 (HGNC:25891): (carbonyl reductase 4) Enables several functions, including 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; NADPH binding activity; and NADPH dehydrogenase (quinone) activity. Involved in fatty acid biosynthetic process; glycoside metabolic process; and protein tetramerization. Located in mitochondrial matrix. Part of oxidoreductase complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010469079).
BP6
Variant 4-168898635-T-C is Benign according to our data. Variant chr4-168898635-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 136014.
BS2
High AC in GnomAd4 at 153 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001166108.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALLD
NM_001166108.2
MANE Select
c.2393T>Cp.Met798Thr
missense
Exon 14 of 22NP_001159580.1Q8WX93-9
PALLD
NM_016081.4
c.2342T>Cp.Met781Thr
missense
Exon 13 of 21NP_057165.3
PALLD
NM_001166109.2
c.1196T>Cp.Met399Thr
missense
Exon 12 of 19NP_001159581.1Q8WX93-8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALLD
ENST00000505667.6
TSL:1 MANE Select
c.2393T>Cp.Met798Thr
missense
Exon 14 of 22ENSP00000425556.1Q8WX93-9
PALLD
ENST00000261509.10
TSL:1
c.2342T>Cp.Met781Thr
missense
Exon 13 of 21ENSP00000261509.6Q8WX93-2
PALLD
ENST00000507735.6
TSL:1
c.881T>Cp.Met294Thr
missense
Exon 5 of 12ENSP00000424016.1Q8WX93-4

Frequencies

GnomAD3 genomes
AF:
0.00101
AC:
153
AN:
152194
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00201
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.00104
AC:
261
AN:
251370
AF XY:
0.00104
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000231
Gnomad NFE exome
AF:
0.00205
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.00202
AC:
2948
AN:
1461822
Hom.:
5
Cov.:
31
AF XY:
0.00189
AC XY:
1371
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33478
American (AMR)
AF:
0.0000447
AC:
2
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000290
AC:
25
AN:
86258
European-Finnish (FIN)
AF:
0.000187
AC:
10
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00255
AC:
2830
AN:
1111950
Other (OTH)
AF:
0.00121
AC:
73
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
148
296
443
591
739
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00100
AC:
153
AN:
152312
Hom.:
0
Cov.:
32
AF XY:
0.00103
AC XY:
77
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41576
American (AMR)
AF:
0.0000654
AC:
1
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00201
AC:
137
AN:
68020
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00165
Hom.:
2
Bravo
AF:
0.00107
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00256
AC:
22
ExAC
AF:
0.00101
AC:
123
EpiCase
AF:
0.00131
EpiControl
AF:
0.00172

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Pancreatic cancer, susceptibility to, 1 (2)
-
-
1
not provided (1)
-
1
-
not specified (1)
-
-
1
Pancreatic adenocarcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
14
DANN
Benign
0.89
DEOGEN2
Benign
0.029
T
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.46
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.53
T
M_CAP
Benign
0.0065
T
MetaRNN
Benign
0.010
T
MetaSVM
Benign
-1.1
T
PhyloP100
1.5
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.64
N
REVEL
Benign
0.059
Sift
Benign
0.17
T
Sift4G
Benign
0.18
T
Vest4
0.31
MVP
0.24
MPC
0.23
ClinPred
0.0093
T
GERP RS
1.8
gMVP
0.27
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142116575; hg19: chr4-169819786; API